Treatment for a 16-Year-Old Boy with Anxiety and Panic Attacks Impairing School and Social Functioning
Start combination therapy with cognitive-behavioral therapy (CBT) plus an SSRI (specifically sertraline) immediately, as this approach demonstrates superior efficacy compared to either treatment alone for adolescents with functionally impairing anxiety and panic disorder. 1
Initial Treatment Algorithm
First-Line: Combination Therapy
Combination treatment with CBT plus sertraline is the gold standard for adolescents aged 6-18 years with functionally impairing anxiety and panic disorder, showing moderate to high strength of evidence for improved anxiety symptoms, global function, treatment response, and disorder remission compared to monotherapy. 2, 1 The Child-Adolescent Anxiety Multimodal Study (CAMS) demonstrated that combination treatment was significantly superior to either CBT alone or medication alone, and initial treatment response strongly predicted long-term outcomes. 1
Medication Component: SSRI Initiation
Start sertraline at 25 mg daily for 3-7 days, then increase to 50 mg daily by week 1-2, with a target therapeutic dose of 50-175 mg daily. 3 This gradual titration minimizes initial anxiety, agitation, or activation symptoms that can occur with SSRIs. 4
Alternative SSRI options if sertraline is not tolerated include:
- Escitalopram: Start 5-10 mg daily, target 10-20 mg daily 4, 3
- Fluoxetine: Start 5-10 mg daily, increase by 5-10 mg increments every 1-2 weeks, target 20-40 mg daily 4
Expected timeline for medication response:
- Statistically significant improvement may begin by week 2 4
- Clinically significant improvement expected by week 6 2, 4
- Maximal therapeutic benefit achieved by week 12 or later 2, 4
Cognitive-Behavioral Therapy Component
Refer immediately for individual CBT specifically designed for anxiety and panic disorder, targeting 12-20 structured sessions. 2, 1 Individual CBT is prioritized over group therapy due to superior clinical and cost-effectiveness. 4
Essential CBT elements must include:
- Education about anxiety and panic physiology 2
- Cognitive restructuring to challenge catastrophizing, over-generalization, and negative predictions 2
- Graduated exposure to social and performance situations that trigger panic attacks 1
- Relaxation techniques including deep breathing and progressive muscle relaxation 2
- Interoceptive exposure for panic-related physical sensations 1
Parent involvement is beneficial, particularly if parents themselves have anxiety, as parental anxiety can inadvertently reinforce avoidance behaviors. 1 Consider parental treatment if indicated. 1
School Accommodations
Coordinate immediately with school to implement accommodations for panic attacks, including a safe space and ability to leave class briefly during panic episodes. 1 Specific plans for anxiety management at school can be written into a 504 plan or individualized education plan, such as graduated practice opportunities for social anxiety and graduated school re-entry with contingent rewards. 2, 1
Critical Monitoring Requirements
Monitor weekly for suicidal ideation and behavior, especially in the first weeks after starting or increasing SSRI dose, as adolescents have increased risk with a pooled risk difference of 0.7% vs placebo (number needed to harm = 143). 4, 1, 3
Monitor for common SSRI side effects:
- Nausea, headache, insomnia, nervousness (typically emerge within first few weeks and resolve with continued treatment) 4
- Behavioral activation/agitation (can occur early in treatment) 1
- Sexual dysfunction, dry mouth, diarrhea, somnolence, dizziness 4
Assess treatment response using standardized anxiety rating scales (e.g., HAM-A) to supplement clinical interview, as use of these scales optimizes ability to accurately assess treatment response and remission. 2, 4
If First SSRI Fails After 8-12 Weeks
Switch to a different SSRI (e.g., sertraline to escitalopram or fluoxetine) after 8-12 weeks at therapeutic doses with inadequate response. 4, 3 Alternative options include paroxetine or fluvoxamine, though these carry higher risks of discontinuation symptoms and should be reserved for when first-tier SSRIs fail. 4
Treatment Duration
Continue medication for a minimum of 12-24 months after symptom remission, then taper gradually over 2-4 weeks when discontinuing to avoid withdrawal symptoms, particularly with shorter half-life SSRIs. 4, 3 Choose a stress-free time of year for discontinuation. 5
Critical Pitfalls to Avoid
Do not use benzodiazepines as first-line treatment despite their rapid anxiolytic effect, due to risks of dependence, cognitive impairment, and lack of evidence for long-term efficacy in adolescents. 1 A short-term benzodiazepine (alprazolam 0.25-0.5 mg as needed) may be considered only as a bridge for the first 2-4 weeks while waiting for SSRI onset, but should not be used as monotherapy. 3
Do not use beta-blockers (propranolol, atenolol) for panic disorder treatment, as they do not treat the underlying condition and may provide only symptom relief for palpitations and tremors. 3 Beta-blockers are specifically deprecated for social anxiety disorder based on negative evidence. 4
Do not delay treatment waiting for "the perfect intervention"—early effective treatment predicts better long-term outcomes. 1
Do not treat in isolation—coordinate care between mental health provider, primary care, and school. 1
Do not escalate SSRI doses too quickly—allow 1-2 weeks between increases to assess tolerability and avoid overshooting the therapeutic window, as SSRI response follows a logarithmic model with diminishing returns at higher doses. 4